Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis

Lauralyn McIntyre; Manoj M. Lalu; Katrina Sullivan; Shirley H. J. Mei; David Moher; Dean Fergusson; Alexander T. Strauss; Duncan J. Stewart; Mazen Jasi; Malcolm Macleod; Brent W. Winston; John Marshall; Keith R. Walley

Article2016

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review

Lauralyn McIntyre, David Moher, Dean Fergusson, Katrina Sullivan, Shirley H. J. Mei, Manoj M. Lalu, John C. Marshall, Malcolm D. McLeod, Gilly Griffin, Jeremy Grimshaw, Alexis F. Turgeon, Marc T. Avey, Michael A. Rudnicki, M R Hadian Jazi, Jason Fishman, Duncan J. Stewart

Article2017

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies

Sajit Augustine, Marc T. Avey, Brittany Harrison, Tiffany Locke, Mona Ghannad, David Moher, Bernard Thébaud

Article2017

Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol

Carly C. Barron, Manoj M. Lalu, Duncan J. Stewart, Dean Fergusson, Homer Yang, David Moher, Peter Liu, C. David Mazer, P.J. Devereaux, Lauralyn McIntyre

Preprint2016

Author response: Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

Manoj M. Lalu, Katrina Sullivan, Shirley H. J. Mei, David Moher, Alexander Straus, Dean Fergusson, Duncan J. Stewart, M R Hadian Jazi, Malcolm Macleod, Brent W. Winston, John C. Marshall, Brian Hutton, Keith R. Walley, Lauralyn McIntyre

Article2016

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

Manoj M. Lalu, Katrina Sullivan, Shirley H. J. Mei, David Moher, Alexander Straus, Dean Fergusson, Duncan J. Stewart, M R Hadian Jazi, Malcolm Macleod, Brent W. Winston, John C. Marshall, Brian Hutton, Keith R. Walley, Lauralyn McIntyre

Efficacy and safety of mesenchymal stromal cell therapy in preclinical animal models of sepsis

Abstract

Discussion(0)

Related publications

Efficacy of Mesenchymal Stromal Cell Therapy for Acute Lung Injury in Preclinical Animal Models: A Systematic Review

Mesenchymal Stromal Cell Therapy in Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis of Preclinical Studies

Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol

Author response: Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial

Evaluating mesenchymal stem cell therapy for sepsis with preclinical meta-analyses prior to initiating a first-in-human trial